Literature DB >> 18704536

Biological functions and metabolism of oleoylethanolamide.

Clémentine Thabuis1, Delphine Tissot-Favre, Jean-Baptiste Bezelgues, Jean-Charles Martin, Cristina Cruz-Hernandez, Fabiola Dionisi, Frédéric Destaillats.   

Abstract

The present review is focused on the metabolism and the emerging roles of oleoylethanolamide (OEA) with emphasis on its effects on food intake control and lipid metabolism. The biological mechanism of action, including a non-genomic effect mediated through peroxisome proliferator-activated receptor alpha (PPAR-alpha) and transient receptor potential vanilloid type 1 (TRPV1) receptor, is discussed. The research related to fatty acid ethanolamides has been focused until recently on anandamide and its interaction with cannabinoid receptor subtype 1. The roles of other N-acyl ethanolamine fatty acid derivatives have been neglected until it was demonstrated that OEA can modulate food intake control through interaction with PPAR-alpha. Further investigations demonstrated that OEA modulates lipid and glucose metabolism, and recent study confirmed that OEA is an antagonist of TRVP1. It has been demonstrated that OEA has beneficial effects on health by inducing food intake control, lipid beta-oxidation, body weight loss and analgesic effects. The investigation of the mechanism of action revealed that OEA activates PPAR-alpha and stimulates the vagal nerve through the capsaicin receptor TRPV1. Pre-clinical studies showed that OEA remains active when administered orally.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18704536     DOI: 10.1007/s11745-008-3217-y

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  45 in total

Review 1.  Peroxisome proliferator-activated receptors: nuclear control of metabolism.

Authors:  B Desvergne; W Wahli
Journal:  Endocr Rev       Date:  1999-10       Impact factor: 19.871

2.  Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina.

Authors:  T Bisogno; I Delton-Vandenbroucke; A Milone; M Lagarde; V Di Marzo
Journal:  Arch Biochem Biophys       Date:  1999-10-15       Impact factor: 4.013

3.  Modulation of meal pattern in the rat by the anorexic lipid mediator oleoylethanolamide.

Authors:  Silvana Gaetani; Fariba Oveisi; Daniele Piomelli
Journal:  Neuropsychopharmacology       Date:  2003-04-02       Impact factor: 7.853

Review 4.  International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.

Authors:  Liliane Michalik; Johan Auwerx; Joel P Berger; V Krishna Chatterjee; Christopher K Glass; Frank J Gonzalez; Paul A Grimaldi; Takashi Kadowaki; Mitchell A Lazar; Stephen O'Rahilly; Colin N A Palmer; Jorge Plutzky; Janardan K Reddy; Bruce M Spiegelman; Bart Staels; Walter Wahli
Journal:  Pharmacol Rev       Date:  2006-12       Impact factor: 25.468

5.  Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine.

Authors:  Jin Fu; Giuseppe Astarita; Silvana Gaetani; Janet Kim; Benjamin F Cravatt; Ken Mackie; Daniele Piomelli
Journal:  J Biol Chem       Date:  2006-11-22       Impact factor: 5.157

6.  An anorexic lipid mediator regulated by feeding.

Authors:  F Rodríguez de Fonseca; M Navarro; R Gómez; L Escuredo; F Nava; J Fu; E Murillo-Rodríguez; A Giuffrida; J LoVerme; S Gaetani; S Kathuria; C Gall; D Piomelli
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

7.  Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1.

Authors:  Xiangbin Wang; Rosa Linda Miyares; Gerard P Ahern
Journal:  J Physiol       Date:  2005-02-03       Impact factor: 5.182

8.  Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: Effect of high fat diets.

Authors:  Isabel Matias; Stefania Petrosino; Alessandro Racioppi; Raffaele Capasso; Angelo A Izzo; Vincenzo Di Marzo
Journal:  Mol Cell Endocrinol       Date:  2008-02-09       Impact factor: 4.102

9.  Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol.

Authors:  Tim C Kirkham; Claire M Williams; Filomena Fezza; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

10.  Intestinal levels of anandamide and oleoylethanolamide in food-deprived rats are regulated through their precursors.

Authors:  Gitte Petersen; Camilla Sørensen; Patricia C Schmid; Andreas Artmann; Mads Tang-Christensen; Steen H Hansen; Philip Just Larsen; Harald H O Schmid; Harald S Hansen
Journal:  Biochim Biophys Acta       Date:  2006-01-26
View more
  27 in total

1.  Lipid transport function is the main target of oral oleoylethanolamide to reduce adiposity in high-fat-fed mice.

Authors:  Clémentine Thabuis; Frédéric Destaillats; Didier M Lambert; Giulio G Muccioli; Matthieu Maillot; Touafiq Harach; Delphine Tissot-Favre; Jean-Charles Martin
Journal:  J Lipid Res       Date:  2011-04-24       Impact factor: 5.922

2.  Mechanisms of exercise-induced hypoalgesia.

Authors:  Kelli F Koltyn; Angelique G Brellenthin; Dane B Cook; Nalini Sehgal; Cecilia Hillard
Journal:  J Pain       Date:  2014-12       Impact factor: 5.820

Review 3.  Endocannabinoid signalling in innate and adaptive immunity.

Authors:  Valerio Chiurchiù; Luca Battistini; Mauro Maccarrone
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

4.  Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea.

Authors:  Paula Urquhart; Jenny Wang; David F Woodward; Anna Nicolaou
Journal:  J Lipid Res       Date:  2015-05-31       Impact factor: 5.922

5.  A role for oleoylethanolamide in chronic lymphocytic leukemia.

Authors:  M Masoodi; E Lee; M Eiden; A Bahlo; Y Shi; R B Ceddia; C Baccei; P Prasit; D E Spaner
Journal:  Leukemia       Date:  2014-01-13       Impact factor: 11.528

6.  Symmetrically substituted dichlorophenes inhibit N-acyl-phosphatidylethanolamine phospholipase D.

Authors:  Geetika Aggarwal; Jonah E Zarrow; Zahra Mashhadi; C Robb Flynn; Paige Vinson; C David Weaver; Sean S Davies
Journal:  J Biol Chem       Date:  2020-04-13       Impact factor: 5.157

7.  Leptogenic effects of NAPE require activity of NAPE-hydrolyzing phospholipase D.

Authors:  Zhongyi Chen; Yongqin Zhang; Lilu Guo; Noura Dosoky; Lorenzo de Ferra; Scott Peters; Kevin D Niswender; Sean S Davies
Journal:  J Lipid Res       Date:  2017-06-08       Impact factor: 5.922

Review 8.  Upper intestinal lipids regulate energy and glucose homeostasis.

Authors:  Grace W C Cheung; Andrea Kokorovic; Tony K T Lam
Journal:  Cell Mol Life Sci       Date:  2009-06-10       Impact factor: 9.261

9.  Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma.

Authors:  Jodianne T Wood; John S Williams; Lakshmipathi Pandarinathan; David R Janero; Carol J Lammi-Keefe; Alexandros Makriyannis
Journal:  J Lipid Res       Date:  2010-01-13       Impact factor: 5.922

10.  Alkyne lipids as substrates for click chemistry-based in vitro enzymatic assays.

Authors:  Anne Gaebler; Robin Milan; Leon Straub; Dominik Hoelper; Lars Kuerschner; Christoph Thiele
Journal:  J Lipid Res       Date:  2013-05-23       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.